Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study
Version 2 2024-06-05, 11:24
Version 1 2022-11-30, 03:36
journal contribution
posted on 2024-06-05, 11:24 authored by GE Berger, SJ Wood, M Ross, CA Hamer, RM Wellard, G Pell, L Phillips, B Nelson, GP Amminger, Alison YungAlison Yung, G Jackson, D Velakoulis, C Pantelis, H Manji, PD McGorryNeuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study
History
Journal
Current Pharmaceutical DesignVolume
18Pagination
570-575Location
United Arab EmiratesPublisher DOI
ISSN
1381-6128eISSN
1873-4286Language
EnglishPublication classification
C1.1 Refereed article in a scholarly journalIssue
4Publisher
BENTHAM SCIENCE PUBL LTDUsage metrics
Keywords
Science & TechnologyLife Sciences & BiomedicinePharmacology & PharmacyBrain imagingLithiumMagnetic Resonance ImagingPsychosis(Indicated) PreventionNeuroprotectionUltra-High Risk (UHR)At Risk Mental State (ARMS)ETHYL-EICOSAPENTAENOIC ACID1ST-EPISODE PSYCHOSISRESONANCE-SPECTROSCOPYHIPPOCAMPAL PATHOLOGYT2 RELAXOMETRYYOUNG-PEOPLEHUMAN BRAINSCHIZOPHRENIABCL-2GRAY
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC